Leap Therapeutics Statistics
Total Valuation
LPTX has a market cap or net worth of $78.22 million. The enterprise value is $9.55 million.
| Market Cap | 78.22M |
| Enterprise Value | 9.55M |
Important Dates
The next estimated earnings date is Monday, May 13, 2024, before market open.
| Earnings Date | May 13, 2024 |
| Ex-Dividend Date | n/a |
Share Statistics
LPTX has 25.60 million shares outstanding. The number of shares has increased by 80.55% in one year.
| Shares Outstanding | 25.60M |
| Shares Change (YoY) | +80.55% |
| Shares Change (QoQ) | -24.24% |
| Owned by Insiders (%) | 15.88% |
| Owned by Institutions (%) | 20.58% |
| Float | 19.45M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| Forward PS | n/a |
| PB Ratio | 1.35 |
| P/FCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 5.65, with zero debt.
| Current Ratio | 5.65 |
| Quick Ratio | 5.71 |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -133.20% and return on invested capital (ROIC) is -144.73%.
| Return on Equity (ROE) | -133.20% |
| Return on Assets (ROA) | -90.90% |
| Return on Capital (ROIC) | -144.73% |
| Revenue Per Employee | n/a |
| Profits Per Employee | -$1.51M |
| Employee Count | 54 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -15.13% in the last 52 weeks. The beta is 0.59, so LPTX's price volatility has been lower than the market average.
| Beta (1Y) | 0.59 |
| 52-Week Price Change | -15.13% |
| 50-Day Moving Average | 2.77 |
| 200-Day Moving Average | 2.51 |
| Relative Strength Index (RSI) | 54.27 |
| Average Volume (30 Days) | 320,970 |
Short Selling Information
The latest short interest is 1.45 million, so 5.67% of the outstanding shares have been sold short.
| Short Interest | 1.45M |
| Short Previous Month | 1.14M |
| Short % of Shares Out | 5.67% |
| Short % of Float | 7.46% |
| Short Ratio (days to cover) | 2.75 |
Income Statement
| Revenue | n/a |
| Gross Profit | n/a |
| Operating Income | -87.04M |
| Pretax Income | -81.41M |
| Net Income | -81.41M |
| EBITDA | -81.40M |
| EBIT | -81.41M |
| Earnings Per Share (EPS) | -$3.98 |
Balance Sheet
The company has $71.61 million in cash and no debt, giving a net cash position of $71.61 million or $2.80 per share.
| Cash & Cash Equivalents | 71.61M |
| Total Debt | n/a |
| Net Cash | 71.61M |
| Net Cash Per Share | $2.80 |
| Equity / Book Value | 60.14M |
| Book Value Per Share | 2.35 |
| Working Capital | 58.91M |
Cash Flow
| Operating Cash Flow | -43.75M |
| Capital Expenditures | n/a |
| Free Cash Flow | -43.75M |
| FCF Per Share | -$2.14 |
Margins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
LPTX does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -80.55% |
| Shareholder Yield | -80.55% |
| Earnings Yield | -100.31% |
| FCF Yield | -53.91% |
Analyst Forecast
The average price target for LPTX is $11.38, which is 261.27% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $11.38 |
| Price Target Difference | 261.27% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 4 |
| Revenue Growth Forecast (5Y) | n/a |
| EPS Growth Forecast (5Y) | -34.10% |
Stock Splits
The last stock split was on June 21, 2023. It was a reverse split with a ratio of 1:10.
| Last Split Date | Jun 21, 2023 |
| Split Type | Reverse |
| Split Ratio | 1:10 |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 1 |